The proportion of patients who have been evaluated for diabetes related morbidities is very low.
Our definitions were intended to exclude individuals being evaluated for diabetes who did not actually have the disease.
Our data do not pertain to other salicylate agents currently being evaluated for diabetes treatment or to intermediate or high doses of long-term aspirin in primary prevention.
Three hundred and ninety-eight consecutive diabetic patients from a single outpatient clinic received a standardized questionnaire on osteoporosis risk factors, and were evaluated for diabetes-related complications, HbA1c levels, and lumbar spine (LS) and femoral neck (FN) BMD.
The high levels of ankyrin-B expression in the brain and pancreatic beta cells and early senescence in ankyrin-B+/− mice suggests that human populations with age-related neurological disorders and/or type 2 diabetes should be evaluated for ANK2 variants.
Everyone 50 and older with diabetes, those who are or were longtime smokers and people with a history of heart attacks or strokes should be evaluated for the disease.
Get in an be evaluated for endometriosis.
A total of 1,029 children with type 1 diabetes and 751 nondiabetic control subjects from 15 studies were evaluated for the overall diabetes versus control comparisons (3, 5, 6, 8, 11– 21) (online appendix Table 1, available at http://dx.doi.org/10.2337/dc07-2132).
We included studies reporting diabetes risk assessment tools or scores that 1) were derived from or validated in prospective cohort studies, 2) were derived in the general adult population and were evaluated for individuals without diabetes at baseline, and 3) reported a measure of performance of the risk score for predicting incident diabetes.
Participants without diabetes at baseline were evaluated for incident type 2 diabetes 13 years later.
We recruited 146 patients with diabetes who were evaluated for microvascular complications at the diabetes clinic of Soonchunhyang University Bucheon Hospital from April 2012 to February 2014.
